Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/198073
Title: | Systemic regulatory T cells and IL-6 as prognostic factors for anatomical improvement of uveitic macular edema |
Author: | Matas, Jessica Llorenç, Victor Fonollosa, Alex Díaz Valle, David Esquinas López, Cristina Sainz de la Maza Serra, María Teresa Figueras-Roca, Marc Artaraz, Joseba Berasategui, Barbara Mesquida, Marina Adán Civera, Alfredo Molins, Blanca |
Keywords: | Marcadors bioquímics Citometria de fluxe Edema Inflamació Biochemical markers Flow cytometry Edema Inflammation |
Issue Date: | 25-Sep-2020 |
Publisher: | Frontiers Media |
Abstract: | Purpose: To investigate whether systemic immune mediators and circulating regulatory T cells (Tregs) could be prognostic factors for anatomic outcomes in macular edema secondary to non-infectious uveitis (UME). Methods: Multicenter, prospective, observational, 12-month follow-up study of 60 patients with UME. Macular edema was defined as central subfield thickness (CST) > 300 μm measured with spectral domain optical coherence tomography (SD-OCT). Serum samples and peripheral blood mononuclear cells (PBMC) were obtained from venous blood extraction at baseline. Serum levels of IL-1β, IL-6, IL-8, IL-17, MCP-1, TNF-α, IL-10, and VEGF were determined by Luminex. Tregs population, defined as CD3+CD4+FoxP3+ in PBMC, was determined by flow cytometry. Main outcome measure was the predictive association between searched mediators and CST sustained improvement, defined as CST < 300 microns or a 20% CST decrease, at 6 months maintained until 12-months compared to baseline levels. Results: Multivariate logistic regression analysis showed an association between CST sustained improvement at 12 months follow-up and IL-6 and Tregs baseline levels. Higher IL-6 levels were associated with less events of UME improvement (OR: 0.67, 95% CI (0.45-1.00), P = 0.042), whereas higher levels of Tregs favored such improvement (OR: 1.25, 95% CI: 1.12-2.56, P = 0.049). Conclusions: Increased levels of Tregs and reduced levels of IL-6 in serum may be prognostic factors of sustained anatomical improvement in UME. These findings could enforce the opportunity to develop more efficient and personalized therapeutic approaches to improve long-term visual prognosis in patients with UME. |
Note: | Reproducció del document publicat a: https://doi.org/10.3389/fimmu.2020.579005 |
It is part of: | Frontiers in Immunology, 2020, vol. 11, p. 579005 |
URI: | http://hdl.handle.net/2445/198073 |
Related resource: | https://doi.org/10.3389/fimmu.2020.579005 |
ISSN: | 1664-3224 |
Appears in Collections: | Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
725122.pdf | 600.48 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License